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Abstract 18 
Production of steroid hormones is complex and dependent upon steroidogenic enzymes, 19 
cofactors, receptors, and transporters expressed within a tissue. Collectively, these factors create 20 
an environment for tissue-specific steroid hormone profiles and potentially tissue-specific 21 
responses to drug administration. Our objective was to assess steroid production, including 22 
sulfated steroid metabolites in the boar testis, prostate, and liver following inhibition of 23 
aromatase, the enzyme that converts androgen precursors to estrogens. Boars were treated with 24 
the aromatase inhibitor, letrozole from 11 to 16 weeks of age and littermate boars received the 25 
canola oil vehicle.  Steroid profiles were evaluated in testes, prostate, and livers of 16, 20, and 40 26 
week old boars using liquid chromatography/mass spectrometry. Testis, prostate, and liver had 27 
unique steroid profiles in vehicle-treated animals. Only C18 steroid hormones were altered by 28 
treatment with the aromatase inhibitor, letrozole; no significant differences were detected in any 29 
of the C19 or C21 steroids evaluated. Testis was the only tissue with significantly decreased free 30 
estrogens following treatment with the aromatase inhibitor; estrone and estradiol concentrations 31 
were lower (p < 0.05) in testes from 16, 20, and 40 week letrozole-treated boars. However, 32 
concentrations of the sulfated conjugates, estrone-sulfate and estradiol-sulfate, were significantly 33 
decreased (p<0.05) in 16 and 20 week boar testes, prostates, and livers from letrozole-treated 34 
boars. Hence, the distribution of estrogens between the free and conjugated forms was altered in 35 
a tissue-specific manner following inhibition of aromatase.  The results suggest sulfated 36 
testicular estrogens are important estrogen precursors for the prostate, potentially enabling 37 
peripheral target tissues to synthesize free estrogens in the male pig.  38 
 39 
KEYWORDS 40 
Estradiol Sulfate, Steroidogenesis, Boar, Male Reproduction, Prostate, Estradiol 41 
3 
 
Introduction  42 
To fully understand steroid hormone synthesis, regulation, and the mechanisms involved 43 
is challenging. Interplay and regulation of enzymes, cofactors, receptors, steroid hormones, and 44 
protein hormones within a single tissue are complex (1-10). Recently, the role of steroid sulfates 45 
and the expression of sulfotransferase and sulfatase have been recognized as critical players in 46 
the regulation of steroid hormone production in a tissue (7, 11). Quantitatively, the most 47 
important steroid hormone in the human circulation is dehydroepiandrostenedione-sulfate 48 
(DHEA-sulfate) with concentrations 100-10,000 times higher than circulating androgens and 49 
estrogens (12). The classical theory was that sulfate conjugation was strictly for enhanced 50 
clearance of steroid hormones due to increased water solubility and inability to bind to steroid 51 
receptors (13). More recently, increased biological half-life of sulfo-conjugates and desulfation 52 
as a path to free steroids are recognized as potential alternative roles (1, 2, 7, 14). 53 
The boar is a distinctive model amongst male mammals because the testes produce high 54 
levels of circulating estrogens (15, 16). The boar also possesses reproductive attributes such as 55 
large accessory sex glands and testes, large ejaculate volume, highly developed interstitial tissues 56 
in the testis, and the extensive steroid producing capabilities of the Leydig cells (15, 17). To 57 
better understand the regulation and synthesis of steroid hormones, specifically estrogens, in the 58 
boar, we utilized an aromatase inhibitor, letrozole. Aromatase catalyzes the rate-limiting step in 59 
estrogen biosynthesis, the conversion of C19 androgens to C18 estrogens (18, 19). Previously, 60 
our laboratory developed a letrozole-treated boar model to evaluate the influences of endogenous 61 
estrogens on the reproductive development of boars (20-25). Although no effect of letrozole 62 
treatment on androgens had been detected in the prior work, effects of this inhibition of 63 
aromatase on less abundant androgens and other steroids in the testis and in other tissues 64 
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remained unanswered.  The questions of why the boar produces or requires the large amount of 65 
endogenous estrogens synthesized (26), and which mechanisms regulate this synthesis (27, 28) 66 
are not understood.  67 
The potential roles of steroid sulfates, specifically DHEA-sulfate and estrogen sulfates, in 68 
steroid hormone production and distributions are intriguing, given the substantial amounts of 69 
sulfated steroid hormones in the boar (29, 30). This study focuses on the interplay between free 70 
and conjugated steroid hormones in a tissue. Raeside et al. called for a more complete profile of 71 
steroid hormones in the boar testis, specifically estrogens (15) and the critical need to better 72 
understand local metabolism of steroid hormones within a tissue (31). To address this critical 73 
gap, over 200 different C21, C19 and C18 steroids were assessed in testis, prostate, and liver at 74 
different developmental stages in boars treated with letrozole during the late juvenile interval. 75 
The multi-tissue approach in combination with a broad investigation of steroids  and aromatase 76 
inhibition, revealed the complexity and unique role each organ has in steroid hormone synthesis. 77 
These data allow consideration of the roles of the testis, prostate, and liver in endogenous 78 
estrogen regulation and steroid hormone production. 79 
Materials and methods  80 
Animal treatment, tissue collection, and experimental design 81 
Animals were treated humanely in strict accordance with protocols approved by the 82 
University of California, Davis Institutional Animal Care and Use Committee (#13398 and 83 
#16308). Avoidance of stress was a goal in administration of treatments and all efforts were 84 
made to eliminate suffering. Twenty-four boars were offspring from animals donated by PIC 85 
USA (Franklin, KY, USA) and semen donated by Genus plc (Hendersonville, TN, USA).  86 
Animal procedures have been detailed previously (22, 32). Letrozole was a gift from Ciba-Geigy 87 
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(Basel, Switzerland). Briefly, littermates (total of 24 boars) from five litters were randomly 88 
assigned to either vehicle treatment (n=12) or letrozole treatment (n=12). Between 11 to 16 89 
weeks of age (prepubertal treatment), each boar received weekly oral administration of letrozole 90 
(0.1mg/kg body weight) or canola oil (vehicle treatment) mixed in 50 grams of feed. To collect 91 
tissue specimens, pigs were euthanized by electroshock and subsequent exsanguination at 16, 20, 92 
and 40 weeks of age.  The 16 week age was selected since that is the time when sperm first 93 
appear in the epididymis, 20 weeks was selected since that age was associated with peak 94 
testicular testosterone (33) in this genetic background, and 40 weeks was considered a mature 95 
age to determine if prepubertal letrozole treatment reprogrammed testicular steroid 96 
concentrations.  At each age, one boar treated with letrozole from four different litters and the 97 
corresponding littermate treated with vehicle provided tissue samples. Testis, prostate, and liver 98 
tissue samples were flash-frozen on dry ice and stored at -80 °C until analysis. Only three liver 99 
samples were available to evaluate the 16 week letrozole-treated boars (n=3). 100 
Quantification of steroids  101 
Samples were extracted using a previously described modification (34) of a published 102 
method (35). Briefly, ~200 mg of tissue were homogenized and extracted twice with cold 103 
methanol 1:2, weight: volume. After centrifugation, the methanol supernatants were removed 104 
and stored in -20°C. The remaining pellet was extracted twice with 1ml chloroform, centrifuged, 105 
and the supernatant collected. Both the methanol and chloroform extracts were combined and 106 
dried with a centrifugal concentrator. The residue was reconstituted in 125 µl of methanol, 107 
filtered through a 0.2 μm ultracentrifuge filter (Millipore Inc., St. Louis, MO, USA), and 7 µl 108 
injected into the UPLC/MS-MS. 109 
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The ultra-performance liquid chromatography–electrospray mass spectrometry (UPLC-110 
ESI/MS/MS) system consisted of a Waters Acquity UPLC system (Waters Inc., Milford, MA, 111 
USA) coupled to a Waters Xevo-TQ mass spectrometer (Waters Inc., Milford, MA, USA). A 112 
detailed descriptions of the method used to quantify steroids has been described previously (34, 113 
36). Analytical data were processed by TargetLynx 4.1 software (Waters Inc., Milford, MA, 114 
USA).  115 
Tissue enzymes 116 
 Microsomes were prepared from tissue (from 16 week old animals) homogenized in 117 
0.1M potassium phosphate buffer (pH 7.4) containing 20% glycerol as previously described (37). 118 
Aromatase activity was determined using the tritiated water assay (38).  Steroid sulfatase (STS) 119 
gene expression was evaluated in tissues from 3 animals by qPCR using 120 
TCTGTCACGGGCATTCCATC as the forward primer and CGGAGTTAACGGGTCTGTCT as 121 
the reverse primer.  Product size (89) of the PCR product was validated on an agarose gel.  122 
Efficiency was calculated at 98.6%, R2 for linearity was 0.99 and melt curves indicated a single 123 
product; these observations were validation of the qPCR. The reference gene was RARS (39). 124 
Statistical analysis 125 
 Statistical analysis and principal component analysis of steroid concentrations were 126 
performed using Origin software (OriginLab, Northampton, MA, USA). Tissue steroid 127 
concentrations were analyzed using a fixed model and one-way analysis of variance (ANOVA). 128 
Differences between means from vehicle and letrozole treatments at the same age were evaluated 129 
with Tukey’s honestly significant difference. Effects were considered statistically significant at P 130 
< 0.05. Data were also transformed to improve normality (log, square root, log(square root) or 131 
reciprocal transformations) and ANOVA rerun. The absence of significant treatment effects for 132 
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the C19 and C21 steroids was the same for transformed and nontransformed data.  Detected 133 
treatment effects on the C18 steroids were similar for the transformed and nontransformed data 134 
although P values did vary slightly. Results are presented as means (of the initial data) ± standard 135 
deviation, as a percentage of summed total steroids and as a percentage of each class (C21, C19 136 
and C18). Principal component analysis was used to visualize differences among tissue type and 137 
treatment. Logged transformed data were imported into Origin software with values below the 138 
limit of quantitation input as one half of the limit of detection. Aromatase activity and gene 139 
expression were analyzed using lmer (mixed model with litter as a random factor) and aov (fixed 140 
model) functions in R statistical programs (40). 141 
Results  142 
Letrozole effects on C18, C19, and C21 steroids  143 
 Letrozole administration resulted in statistically significant decreases in estradiol and 144 
estrone concentrations in testes at all ages, while no concentration changes in free estrogens were 145 
observed in prostate or liver (Fig 1A and B). Sulfated conjugates of estradiol and estrone were 146 
significantly decreased in the testis, prostate, and liver from the 16 and 20 week letrozole-treated 147 
boars but not in the 40 week letrozole-treated boars (Fig 1C and D). Interestingly, estradiol 148 
sulfate and estrone sulfate concentrations were similar or lower than their  free forms in the 149 
testis, prostate, and liver tissue extracts from 16 and 20 week letrozole-treated boars but not in 150 
their vehicle-treated littermates (Table 1). Hence, letrozole treatment alters testicular distribution 151 
of C18 steroid hormones in 16 and 20 week boars, but free C18 steroid distributions are less 152 
affected in the prostate and liver (Table 1). Letrozole treatment did not alter any androgen in any 153 
of the three tissues at any time point (Fig 1E and F, Table 1) compared with vehicle-treated 154 
littermates nor did it affect any C21 steroid. 155 
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 156 
Fig 1. Letrozole induced changes in tissue concentrations (pg/g) of estrogens and androgens 157 
in the testis, prostate, and liver. Estrone (A) and estradiol (B) concentrations were decreased in 158 
the testis of 16, 20, and 40 week boars compared with vehicle-treated littermates. Estrone (A) 159 
and estradiol (B) concentrations in the prostate and liver were not affected by letrozole treatment. 160 
Estrone sulfate (C) and estradiol sulfate (D) concentrations were decreased compared with 161 
vehicle-treated littermates at week 16 and 20 in all tissues. The aromatase substrates, 162 
androstenedione (E) and testosterone (F), were not affected in any tissue by letrozole 163 
administration.  * P < 0.05, ** P < 0.01. 164 
Table 1. Steroid content of testis, prostate, and liver from puberal and postpuberal 165 
littermate boars treated with the aromatase inhibitor, letrozole, or with the canola oil 166 
vehicle1. 167 
Testis2 
C18 V-16 L-16 V-20 L-20 V-4   
Estrone 22.07 (9.92) 1.96 (0.78) 17.03 (8.97) 1.88 (0.49) 9.96 (2    
Estrone-3-SO4 76.11 (29.56) 0.92 (0.45) 50.75 (35.24) 2.02 (2.44) 49.52 (1    
Estrone-3-GLU ND ND ND ND ND  
16α-Hydroxyestrone 1.70 (0.68) 0.04 (0.04) 0.68 (0.08) 0.13 (0.11) 0.51 (0    
Estradiol 44.45 (29.11) 7.88 (3.74) 56.26 (27.04) 7.86 (4.62) 39.59 (    
Estradiol-3-SO4 586.5 (246.2) 2.69 (1.14) 381.6 (271.3) 8.30 (8.91) 273.9 (    
Estradiol-3-GLU 0.27 (0.26) 0.12 (0.18) 0.31 (0.62) 0.03 (0.06) 0.02 (0    
Estradiol-17-GLU 3.64 (3.30) 0.66 (0.77) 2.94 (2.18) 0.97 (1.08) 2.13 (2    
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Estriol 0.20 (0.29) trace 0.29 (0.41) 0.01 (0.02) 0.04 (0    
       
C19 V-16 L-16 V-20 L-20 V-4   
Dehydroepiandrosterone 85.96 (23.65) 132.90 (138.80) 98.91 (105.92) 48.55 (45.99) 52.26 (3    
Dehydroepiandrosterone-SO4 237.8 (43.87) 163.7 (179.6) 193.7 (71.79) 125.9 (70.36) 98.37 (1    
5-Androstenediol 75.40 (35.83) 104.3 (107.7) 86.29 (113.7) 37.4 (30.84) 84.27 (8    
4-Androstenediol 5.58 (4.64) 5.01 (4.81) 5.35 (6.13) 1.89 (1.21) 4.77 (3    
Androstenedione 58.11 (31.33) 36.20 (32.91) 53.49 (32.36) 21.24 (9.45) 18.20 (1    
19-Hydroxyandrostendione 12.80 (14.66) 0.35 (0.34) 10.60 (11.26) 0.93 (0.99) 2.61 (1    
Testosterone 236.2 (130.6) 157.8 (192.4) 166.5 (92.85) 84.42 (59.00) 61.86 (3    
Epitestosterone 4.50 (2.95) 2.42 (3.65) 4.81 (2.94) 2.32 (0.76) 1.01 (0    
Epi/Testosterone-SO4 12.60 (6.59) 11.32 (4.70) 8.44 (6.36) 4.27 (2.42) 4.56 (3    
5α-Dihydrotestosterone 1.87 (1.88) 4.39 (6.76) 2.42 (2.58) 3.12 (3.31) 0.54 (0    
6-Ketotestosterone 59.83 (96.59) 55.22 (75.38) 45.08 (55.70) 33.28 (27.30) 7.44 (1    
6-Dehydrotestosterone 0.86 (0.46) 0.40 (0.25) 0.29 (0.15) 0.30 (0.09) 0.21 (0    
17β-Dihydroepiandrosterone 181.7 (162.6) 174.8 (242.7) 151.0 (170.3) 98.98 (46.79) 130.6 (9    
6α-Hydroxytestosterone 12.16 (8.52) 3.54 (6.53) 9.13 (6.32) 2.02 (3.49) 1.49 (0    
Adrenosterone 2.74 (2.82) 2.37 (2.47) 1.40 (0.89) 1.49 (1.15) 0.39 (0    
Epiandrosterone 12.85 (7.10) 15.66 (26.94) 10.91 (7.72) 10.13 (14.69) 3.81 (4    
       
C21       
Pregnenolone 835.4 (357.8) 822.5 (462.5) 739.8 (594.0) 806.3 (725.1) 484.4 (1    
Pregnenolone-3-SO4 59.3 (11.5) 130.6 (177.8) 66.7 (52.8) 87.7 (77.3) 39.8 (2    
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17-Hydroxypregnenolone 396.0 (265.0) 406.5 (360.5) 421.4 (507.5) 395.9 (536.0) 255.1 (2    
Progesterone 6.92 (2.26) 10.30 (6.50) 9.03 (9.34) 16.86 (23.74) 5.08 (4    
17-Hydroxyprogesterone 2.52 (1.01) 4.04 (2.70) 3.48 (3.44) 4.68 (4.61) 2.89 (2    
11-Deoxycortisol 2.88 (2.15) 1.07 (0.72) 2.25 (1.42) 0.95 (0.71) 0.97 (0    
Cortisol 4.14 (4.13) 0.69 (0.79) 3.27 (3.09) 1.01 (0.99) 2.10 (1    
Deoxycorticosterone 1.59 (1.22) 0.50 (0.43) 1.35 (1.02) 0.44 (0.26) 0.44 (0    
Corticosterone 0.27 (0.52) 0.41 (0.43) 1.02 (1.81) 0.16 (0.12) 0.37 (0    
Epiallopregnanolone 78.13 (62.52) 120.8 (147.3) 81.82 (97.05) 162.6 (179.2) 81.87 (9    
Allo/Pregnanolone-SO4 1.59 (1.36) 3.78 (3.38) 0.93 (0.61) 1.90 (1.84) 0.42 (0    
Epi/Epiallopregnanolone-SO4 2.91 (1.80) 21.39 (35.92) 7.94 (11.73) 14.97 (18.26) 4.37 (5    
       
Prostate3 
C18 V-16 L-16 V-20 L-20 V-4   
Estrone 3.64 (1.86) 1.59 (0.51) 2.14 (0.92) 2.04 (1.18) 2.94 (2    
Estrone-3-SO4 9.37 (7.78) 0.36 (0.19) 5.27 (2.42) 0.49 (0.12) 9.32 (8    
Estrone-3-GLU ND ND ND ND ND  
16α-Hydroxyestrone ND ND ND ND ND  
Estradiol 18.33 (8.28) 11.80 (5.35) 15.50 (10.56) 13.34 (7.89) 19.43 (1    
Estradiol-3-SO4 7.44 (5.38) 0.54 (0.42) 4.28 (1.64) 0.73 (0.99) 10.86 (1    
Estradiol-3-GLU 0.35 (0.57) 0.002 (0.002) 0.05 (0.09) 0.12 (0.17) 1.31 (0    
Estradiol-17-GLU 0.42 (0.72) 0.002 (0.001) 0.20 (0.40) 1.51 (2.00) 1.40 (1    
Estriol ND ND ND ND ND  
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C19       
Dehydroepiandrosterone ND ND ND ND ND  
Dehydroepiandrosterone-SO4 29.29 (19.57) 9.89 (7.27) 15.36 (5.18) 12.16 (7.53) 31.03 (2    
5-Androstenediol ND ND ND ND ND  
4-Androstenediol ND ND ND ND ND  
Androstenedione 0.26 (0.10) 0.24 (0.09) 0.22 (0.10) 0.13 (0.06) 0.38 (0    
19-Hydroxyandrostendione ND ND ND ND ND  
Testosterone 1.67 (0.32) 1.04 (1.67) 0.36 (0.15) 0.55 (0.29) 1.07 (0    
Epitestosterone 0.01 (0.02) 0.09 (0.07) 0.02 (0.02) 0.09 (0.10) 0.27 (0    
Epi/Testosterone-SO4 ND ND ND ND ND  
5α-Dihydrotestosterone 2.51 (1.10) 1.79 (1.17) 1.29 (0.84) 1.23 (0.39) 0.93 (0    
6-Ketotestosterone ND ND ND ND ND  
6-Dehydrotestosterone ND ND ND ND ND  
17β-Dihydroepiandrosterone trace trace trace trace trac   
6α-Hydroxytestosterone ND ND ND ND ND  
Adrenosterone ND ND ND ND ND  
Epiandrosterone 4.76 (2.82) 6.24 (5.94) 6.01 (4.52) 7.01 (4.62) 4.41 (3    
       
C21       
Pregnenolone ND ND ND ND ND  
Pregnenolone-3-SO4 0.49 (0.39) 0.36 (0.29) 0.42 (0.19) 1.29 (0.88) 0.98 (0     
17-Hydroxypregnenolone ND ND ND ND ND  
Progesterone 0.70 (0.34) 0.31 (0.21) 0.73 (0.86) 1.64 (2.36) 0.58 (0    
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17-Hydroxyprogesterone ND ND ND ND ND  
11-Deoxycortisol ND ND ND ND ND  
Cortisol 2.85 (1.87) 0.86 (0.72) 3.13 (4.05) 3.39 (3.70) 3.38 (3    
Deoxycorticosterone 0.24 (0.36) 0.11 (0.10) 0.24 (0.26) 0.24 (0.25) 0.07 (0    
Corticosterone 1.84 (1.38) 0.36 (0.50) 0.82 (1.15) 2.32 (3.12) 0.26 (0    
Epiallopregnanolone ND ND ND ND ND  
Allo/Pregnanolone-SO4 ND ND ND ND ND  
Epi/Epiallopregnanolone-SO4 trace trace trace trace trac   
 
Liver4 
C18 V-16 L-16 V-20 L-20 V-4   
Estrone 0.22 (0.03) 0.33 (0.13) 0.53 (0.20) 0.41 (0.05) 0.48 (0    
Estrone-3-SO4 4.84 (3.40) 0.06 (0.04) 6.02 (1.51) 0.26 (0.39) 6.85 (4    
Estrone-3-GLU 1.06 (0.36) 0.12 (0.22) 0.14 (0.13) 0.36 (0.44) 1.40 (2    
16α-Hydroxyestrone 0.01 (0.003) 0.03 (0.01) 0.02 (0.01) 0.02 (0.01) 0.02 (0    
Estradiol 1.27 (0.05) 1.68 (0.84) 2.89 (2.07) 1.47 (0.50) 2.40 (0    
Estradiol-3-SO4 14.26 (15.44) 0.13 (0.08) 34.31 (12.07) 1.35 (1.70) 67.40 (4    
Estradiol-3-GLU 1.19 (1.33) 0.004 (0.01) 0.95 (0.88) 0.02 (0.02) 3.05 (3    
Estradiol-17-GLU 1.11 (1.57) 0.32 (0.64) 0.57 (0.47) 0.13 (0.15) 1.79 (0    
Estriol 0.07 (0.10) trace 0.16 (0.23) trace 0.01 (0    
       
C19 V-16 L-16 V-20 L-20 V-4   
Dehydroepiandrosterone ND ND ND ND ND  
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Dehydroepiandrosterone-SO4 11.14 (4.38) 6.96 (3.49) 16.70 (4.33) 11.66 (10.59) 17.78 (1    
5-Androstenediol ND ND ND ND ND  
4-Androstenediol ND ND ND ND ND  
Androstenedione 0.07 (0.01) 0.13 (0.05) 0.34 (0.23) 0.17 (0.08) 0.11 (0    
19-Hydroxyandrostendione ND ND ND ND ND  
Testosterone 0.19 (0.01) 0.31 (0.27) 0.43 (0.05) 0.65 (0.32) 0.60 (0    
Epitestosterone 0.26 (0.08) 0.18 (0.15) 0.14 (0.11) 0.25 (0.23) 0.20 (0    
Epi/Testosterone-SO4 2.35 (2.00) 2.15 (2.10) 2.87 (0.76) 2.90 (3.31) 4.93 (2    
5α-Dihydrotestosterone 0.04 (0.06) 0.09 (0.10) 0.04 (0.07) 0.01 (0.02) 0.13 (0    
6-Ketotestosterone ND ND ND ND ND  
6-Dehydrotestosterone ND ND ND ND ND  
17β-Dihydroepiandrosterone ND ND ND ND ND  
6α-Hydroxytestosterone ND ND ND ND ND  
Adrenosterone ND ND ND ND ND  
Epiandrosterone ND ND ND ND ND  
       
C21 V-16 L-16 V-20 L-20 V-4   
Pregnenolone ND ND ND ND ND  
Pregnenolone-3-SO4 0.60 (0.02) 0.71 (0.86) 0.87 (0.54) 1.07 (0.64) 0.95 (0     
17-Hydroxypregnenolone ND ND ND ND ND  
Progesterone 0.06 (0.03) 0.17 (0.11) 1.09 (1.16) 1.05 (1.09) 0.30 (0    
17-Hydroxyprogesterone ND ND ND ND ND  
11-Deoxycortisol 0.14 (0.08) 0.28 (0.25) 2.04 (2.09) 1.87 (1.86) 0.36 (0    
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Cortisol 0.47 (0.06) 1.64 (2.25) 13.23 (12.51) 7.73 (8.98) 1.40 (1    
Deoxycorticosterone 0.03 (0.01) 0.04 (0.04) 0.38 (0.33) 0.36 (0.45) 0.11 (0    
Corticosterone 0.20 (0.21) 0.30 (0.26) 0.60 (0.54) 0.86 (0.91) 0.07 (0    
Epiallopregnanolone ND ND ND ND ND  
Allo/Pregnanolone-SO4 ND ND ND ND ND  
Epi/Epiallopregnanolone-SO4 trace trace trace trace trac   
 168 
1Values represent means (SD) in ng/g.  Values in bold indicate statistically significant 169 
differences between letrozole-treated boars and vehicle-treated littermates at the indicated age.   170 
2Values for testis tissue at each age are based upon one boar from each of four litters treated with 171 
letrozole from 11 to 16 weeks of age and littermates treated with the canola oil vehicle.  All 172 
boars came from a total of five litters. 173 
3Values for prostate tissue at each age are based upon one boar from each of four litters treated 174 
with letrozole from 11 to 16 weeks of age (three boars treated with vehicle at 16 weeks of age 175 
and three boars treated with letrozole at 20 weeks of age) and littermates treated with the canola 176 
oil vehicle. Tissues came from same boars that donated testicular tissue.  177 
4Values for liver tissue at each age are based upon one boar from each of four litters treated with 178 
letrozole from 11 to 16 weeks of age (three boars treated with vehicle at 16 weeks of age and at 179 
20 weeks of age) and littermates treated with the canola oil vehicle. Tissues came from same 180 
boars that donated testicular tissue. 181 
 182 
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Testis, prostate, and liver have unique C18, C19, and C21 steroid 183 
profiles 184 
Each tissue had a unique steroid distribution, which drove the clustering of samples in 185 
principal component analysis regardless of treatment group (Figs 2 and 3), although DHEA-186 
sulfate was the predominant C19 steroid hormone in all tissues.  The testes had the most diverse 187 
steroid profile of the three tissues investigated, containing 40 different identified C18, C19, and 188 
C21 steroids (Table 1). This represents a relatively small proportion of the 92 estrogens (C18), 189 
50 androgens (C19), and 60 progestogens and gluco/mineralocorticoids (C21) that might have 190 
been detected with this method (Table 2). Quantitatively, the C21 steroids had the largest overall 191 
contribution in the testes, followed by C19 and C18 steroids (Table 1). Pregnenolone was the 192 
most abundant steroid in boar testis followed by 17-hydroxypregnenolone or estradiol 3-SO4. 193 
Pregnenolone levels were twice the concentration of 17-hydroxypregnenolone and five or more 194 
fold higher than any other C21 steroid in the testis in all boars. Interestingly, neither 195 
pregnenolone nor 17-hydroxypregnenolone was detected in prostate or liver. Pregnenolone-196 
sulfate was detected in all three tissues with concentrations in testis being 20 or more fold higher 197 
than concentrations in the prostate and liver.   198 
 199 
Fig 2. Principal component analysis of steroids in the boar testis, prostate, and liver. The 200 
source organ was the primary influence for clustering of steroid profiles rather than age or 201 
treatment. The first two of the principal components accounted for 68% of the total variance 202 
(54% and 14%) and remaining calculated components each explained 2-7% of the total variance 203 
and were not subsequently considered. 204 
 205 
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Fig 3. Steroid distributions of C18, C19, and C21 in the testis, prostate, and liver. C18 206 
steroids (A-C) consist of estrogen derivatives, C19 steroids (D-F) consist of androgen 207 
derivatives, and C21 steroids (G-I) consist of progestogens, gluco/mineralocorticoids, and 208 
derivatives. Each tissue had a distinct profile.  C refers to vehicle-treated littermates and L to 209 
letrozole-treated littermates. The number following C or L refers to the age of the animal at 210 
tissue recovery. Data based on nmol/g tissue. 211 
 212 
Table 2.  List of steroids evaluated in profile. 213 
Steroid LOD1 Steroid LOD1 
Pregnenolone 1.58 Estradiol-3-hemisuccinate 0.001 
17-Hydroxypregnenolone 1.504 Estrone-3-hemisuccinate 0.007 
Dehydroepiandrosterone 0.087 Estradiol-17-hemisuccinate 0.268 
5-Androstenediol 0.172 Estradiol-3,17-di-hemisuccinate 0.001 
Progesterone 0.003 Estriol-3-hemisuccinate 0.064 
17-Hydroxyprogesterone 0.007 Allopregnanolone 0.785 
11-Deoxycortisol 0.007 Alldihydroprogesterone 1.58 
Cortisol 0.068 Allopregnanediol 0.1 
11-Deoxycorticosterone 0.015 11α-Hydroxyprogesterone 0.757 
Corticosterone 0.072 11β-Hydroxyprogesterone 0.076 
Aldosterone 0.693 21-Hydroxypregnanolone 3.008 
Androstenedione 0.009 21-Hydroxypregnenolone 3.008 
Testosterone 0.009 7α-Hydroxypregnenolone 3.008 
5α-Dihydrotestosterone 0.344 2α-Hydroxytestosterone 0.81 
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Estrone 0.009 20α-Hydroxy-5a-pregnan-3-one 0.785 
Estradiol 0.009 20α-Hydroxyprogesterone 0.521 
11α-Hydroxyestrone 0.087 17α-20a-Dihydroprogesterone 0.923 
11β-Hydroxyestrone 0.873 Pregnenolone-SO4 0.063 
11α-Hydroxyestradiol 0.173 Pregnanolone 0.785 
11β-Hydroxyestradiol 1.734 Pregnanediol 1.56 
9(11)-Dehydroestradiol 0.092 Pregnanedione 1.58 
9(11)-Dehydroestrone 0.093 Epiallopregnanolone  1.36 
11-Ketoestrone 0.088 17β-Dihydroandrosterone 3.419 
Estradiol-3-SO4 0.025 17β-Dihydroepiandrosterone 1.71 
Estrone-3-SO4 0.076 7α-Hydroxytestosterone 0.821 
Estradiol-17-SO4 0.049 7α-Hydroxyandrostenedione 0.083 
Estradiol-3,17-SO4 0.216 6α-Hydroxytestosterone 0.019  
3-o-methoxy-estrone 0.009 6β-Hydroxytestosterone  .  
Estradiol-3-GLU 1.062 Dehydroepiandrosterone-GLU 3.46 
Estrone-3-GLU 0.073 16α-Hydroxydehydroepiandrosterone 8.55 
Estradiol-17-GLU 1.062 Testosterone-SO4 0.062 
Estrone-3,17-GLU 0.327 Desoxytestosterone 0.544 
4-Hydroxyestrone 0.002 Testosterone-GLU 0.166 
4-Hydroxyestradiol 0.347 4-Androsten-3α-ol-17-one 2.19 
4-o-Methoxy-estrone 0.083 2α-Hydroxyandrostenedione 6.22 
4-o-Methoxy-estradiol 3.307 11α-Hydroxyandrostenedione 1.84 
4-o-Methoxy-estriol 15.703 6-Ketotestosterone 0.413 
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4-Hydroxy-estrone-2-SG 0.042 11-Ketotestosterone 0.928 
4-Hydroxy-estradiol-2-SG 0.169 9-Dehydrotestosterone  . 
4-Hydroxy-estrone-2-CYS 0.025 Allotetrahydrocortexone  . 
4-Hydroxy-estradiol-2-CYS 0.614 Adrenosterone 0.227  
4-Hydroxy-estrone-2-NAcCYS 0.224 Etiocholanolone  .  
4-Hydroxy-estradiol-2-NAcCYS 0.223 4-Androstenediol 0.826 
4-Hydroxy-estrone-1-N3Ade 0.012 16α-Ketotestosterone 2.21 
4-Hydroxy-estradiol-1- N3Ade  0.024 19-Hydroxyandrostenedione 0.235 
4-Hydroxy-estrone-1-N7Gua 0.23 4-Androsten-3,6-17-trione 2.63 
4-Hydroxy-estradiol-1- N7Gua  0.229 7β-Hydroxydehydroepiandrosterone 6.24 
2-Hydroxyestrone 0.349 7α-Hydroxydehydroepiandrosterone 6.22 
2-Hydroxyestradiol 0.347 7-Ketodehydroepiandrosterone 1.12 
2-Hydroxy-estrone-1+4-SG 0.423 9-Dehydroepiandrosterone  . 
2-Hydroxy-estradiol-1+4-SG  0.421 Cortisone  . 
2-Hydroxy-estrone-1+4-Cys 0.247 9-Dehydroprogesterone 5.29 
2-Hydroxy-estradiol-1+4-Cys  0.614 11-Dehydrotetrahydrocosticosterone 0.814 
2-Hydroxy-estrone-1+4-NAcCys 0.112 Tetrahydrocorticosterone  . 
2-Hydroxy-estradiol-1+4-S 
NAcCys 
0.557 6β-Hydroxycorticosterone 0.618 
2-Hydroxyestrone-6-N3Ade 0.119 5α-Dihydrocorticosterone 1.66 
2-Hydroxyestradiol-6-N3Ade 0.119 5α-Dihydropregnanolone  . 
2-Hydroxyestriol 0.008 Tetrahydrocortisol  . 
3-Methoxy-2-hydroxy-estrone 0.166 Pregnanetriol 1.31 
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2-Methoxy-3-hydroxy-estrone 0.008 Allotetrahydrocortisol  . 
2-Methoxy-3-hydroxy-estradiol 0.331 16α-Hydroxyprogesterone 2.25 
2,3 Dimethoxy-estrone 0.032 6-Dehydrotestosterone 3.27 
2,3 Dimethoxy-estradiol 0.079 9(11)-Didehydroepiandrosterone 9.36 
6α-Hydroxyestradiol 0.173 11β-Hydroxyepiandrosterone 1.28 
6β-Hydroxyestradiol 0.173 16α-Hydroxyepiandrosterone 8.55 
6-Ketoestrone 0.088 Androsterone  . 
6-Ketoestradiol 0.087 Epiandrosterone 0.67 
6-Dehydroestradiol  0.092 7α-Hydroxyandrostenediol 1.38 
6-Dehydroestrone 0.019 7β-Hydroxyandrostenediol 1.29 
16α-Hydroxyestrone 0.175 5β-Dihydrocorticosterone  . 
17-Epiestriol 0.173 4-Pregnen-3b-ol-20-one 8.06 
Estriol 0.347 Urocortisone 0.067 
16,17-Epiestriol 3.468 5-Androsten-3b,17-diol-16-one 3.94 
16-Epiestriol 3.468 19-Hydroxydehydroepiandrosterone 2.8 
Estriol-3-SO4 0.271 16α-Hydroxypregnenolone 4.401 
 Estriol-3-GLU 2.153 5α-Dihydrocortexone 1.62 
3-Methoxy-estriol 0.002 Epitestosterone 0.174 
16-Keto-17β-estradiol 3.492 5β-Androstanedione  . 
16-Ketoestriol 0.331 11β-Hydroxyandrostenedione  . 
7-Dehydro-17β-estradiol 3.699 11-Ketoetiocholanolone  . 
Equilin 0.019 5α-Pregnan-11a-ol-3,20-dione 2.51 
Dihydroequilin-3-SO4 1.342 5α-Epoxypregnenolone  . 
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Equilin-3-SO4 6.749 Allopregnanetrione  . 
Estrone-9-N3-Ade 0.124 11-Ketoprogesterone 3.12 
Estradiol-9-N3-Ade 0.247 11-Dehydrocorticosterone  . 
Estradiol-3-acetate 0.08 6β-Hydroxycortisol  . 
Estrone-3-acetate 0.16 20β-Dihydrocortisone  . 
Estradiol-3,17α-di-acetate 0.07 6β-Hydroxycortisone  . 
Estradiol-3,17β-di-acetate 1.402 Etiocholanolone-GLU 0.398 
 2-Hydroxy-estradiol-17-acetate 0.003 Dehydroepiandrosterone-SO4 0.198 
6-Ketoestradiol-3,17-di-acetate 0.006 Epitestosterone-SO4 0.181 
6-Ketoestradiol-tri-acetate 0.023 Epitestosterone-GLU 0.126 
6-Dehydroestradiol-di-acetate 0.141 Pregnanediol-GLU 0.0183 
Estriol-3-acetate 0.303 17α-Hydroxypregnanolone-GLU 1.76 
Estriol-16-acetate 0.303 Pregnanolone-SO4 0.133 
Estriol-16,17-diacetate 0.268 17α,20β-Dihydroxyprogesterone-GLU 0.102 
17-Epiestriol triacetate 0.241 Hydrocortisone-21-SO4  . 
Estriol-triacetate 0.006 Pregnenolone-GLU  . 
16,17-Epiestriol triacetate 0.06 Allopregnanolone-SO4 0.014 
16-Epiestriol triacetate 0.121 Epiallopregnanolone-SO4 0.012 
Equilin acetate 0.081 Corticosterone-21-SO4  . 
 214 
1LOD values are estimates of the limit of detection.  Values in italics are based on a limited 215 
assessment and no estimates are available for compounds with a period.  216 
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The prostate contained 20 different identified C18, C19, and C21 steroids (Table 1).  217 
Estradiol or DHEA-sulfate was the most abundant steroid in the prostate. Regardless of 218 
treatment, total C21,C19,C18  steroid concentrations in the prostate were ~50% C18, ~50% C19, 219 
and less than 10% C21 (Table 1).  Total C18 steroids in letrozole-treated animals were less than 220 
half the concentration detected in the testis in vehicle-treated littermates. Most of the C18 221 
steroids were present in an unconjugated form in the prostate in contrast to the conjugated form 222 
in the testis (Fig 4). Only six different C19 steroids were detected in the prostate compared with 223 
17 detected in the testis. Although most C19 steroids were markedly lower in the prostate than 224 
the testis, 5α-dihydrotestosterone had a similar concentration in both tissues.    225 
Fig 4. Distribution of estradiol and estradiol conjugates in testis, prostate, and liver.  226 
Estradiol was the predominant C18 steroid in each of these tissues. The prominence of estradiol 227 
sulfate in testis and liver from vehicle-treated boars contrasts with the limited concentration of 228 
the sulfo-conjugate in the prostate, even in vehicle-treated boars. A shift in distribution between 229 
free estradiol and estradiol sulfate is apparent in the 16 and 20 week letrozole-treated littermates.   230 
C refers to vehicle-treated littermates and L to letrozole-treated littermates. The number 231 
following C or L refers to the age of the animal at tissue recovery.  232 
 The liver contained 23 different identified C18, C19, and C21 steroids. The C18 steroids 233 
quantitatively accounted for over 50% of total steroids in vehicle-treated boars and less than 20% 234 
of the total steroids in the liver from the 16 and 20 week letrozole-treated boars consistent with 235 
reduced production of C18 steroids in these boars (Table 1). Regardless of treatment, steroid 236 
levels in liver tissue were much, much lower than in the testis and total free steroid concentration 237 
was much lower than in the prostate.   238 
Prostate enzymes 239 
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 Aromatase activity in the prostate was detectable but almost 1000 fold lower than that in 240 
the testes of the same animals (0.08 vs 65.20 pmoles/mg protein/h, standard error = 0.27, P < 241 
0.001).  Concentrations of the aromatase precursors, testosterone and androstenedione were quite 242 
low in the prostate (less than 2% of testicular levels) and not affected by letrozole treatment. 243 
Measurable aromatase activity was not detectable in liver tissues from 16 week boars. In 244 
contrast, gene expression for steroid sulfatase (STS), the enzyme involved in removing sulfate, 245 
was detectable in prostate and testis and liver tissues with similar relative gene expression (ΔCt 246 
of 2.88, 1.86, and 2.0 respectively, P > 0.25, standard error = 0.92).    247 
Discussion  248 
 To our knowledge, this study provides the most comprehensive assessment of steroid 249 
tissue concentrations in the boar to date. Although the steroids evaluated were extensive, the 250 
pheromone androstenone was not included in the panel. Testicular concentrations detected in this 251 
study were consistent with the testicular origin indicated for previously described steroid sulfates 252 
(41). In contrast to a previous suggestion that dihydrotestosterone increased from puberty to 253 
maturity (42), our data do not suggest an increase in dihydrotestosterone in either the testis or the 254 
prostate although our data did not include comparisons with prepuberal timepoints. Apparent 255 
age-related decreases in testicular steroids among vehicle-treated boars may reflect increased 256 
testicular mass, due at least in part to increased spermatogenesis. Our multi-tissue approach in 257 
combination with a broad steroid profile provide critical information on the role of each of these 258 
tissues in steroidogenesis, steroid intracrinology, and steroid sulfate metabolism. 259 
Endogenous estrogen synthesis and metabolism  260 
Letrozole administration uniquely affected endogenous C18 steroids in the testis, 261 
prostate, and liver, revealing tissue-specific regulation of estrogens. Testicular estrogens in the 262 
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boar are primarily synthesized locally via aromatization of androgen precursors (27, 41, 43); 263 
testicular estrogen sulfates result from subsequent local conjugation by sulfotransferases (27, 29, 264 
30). Letrozole inhibited testicular aromatase, resulting in the direct decrease in estrone and 265 
estradiol concentrations and an indirect decrease in the corresponding testicular sulfo-conjugate 266 
concentrations. A decrease in 19-hydroxyandrostenedione, an intermediate of aromatase action 267 
on androstenedione, might be expected.  Although values for 19-hydroxyandrostenedione were 268 
numerically much lower in letrozole-treated boars than in vehicle-treated littermates, values were 269 
not significantly different, perhaps due to high variability among boars. Letrozole administration 270 
during the prepuberal interval had a prolonged effect on estrogen production in this study similar 271 
to the reprogramming of aromatase including reduced protein and enzymatic activity observed 272 
long after letrozole administration ceased during the neonatal and juvenile intervals (44). 273 
Estrogen sulfate and free estrogen concentrations were affected differently by letrozole 274 
administration in the prostate and liver; concentrations of free estrogens were unaffected by 275 
letrozole treatment while estrone-sulfate and estradiol-sulfate concentrations were significantly 276 
decreased in tissue from letrozole-treated boars. Consistent with the high levels of sulfatase 277 
present in the prostate (7, 45), in vitro evidence suggests estrone and estradiol are produced in 278 
greater quantities in the human prostate by sulfatase than by aromatase (46). Similarly, the very, 279 
very low aromatase activity we detected in the prostate in conjunction with gene expression for 280 
steroid sulfatase, the enzyme that removes sulfate from sulfated steroids, suggests local 281 
transformation from estrogen sulfates may maintain free estrogen levels in the boar prostate as 282 
well. Higher estradiol concentrations in the prostates from 16 and 20 week letrozole-treated 283 
boars than concentrations in the testes from these same boars are consistent with this suggestion 284 
of local transformation in the prostate distinct from testicular regulation.  The significant 285 
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decrease in estrogen sulfates in the prostate may reflect desulfation of testicular-derived estrogen 286 
sulfates in order to maintain free estrogen concentrations in the prostate.  Furthermore, prostate 287 
intracrine metabolism may enable independent regulation/synthesis of estrogens and androgens 288 
via separate testicular precursors, estrogen sulfate and DHEA-sulfate, respectively.    289 
Dependence of boar prostate size on estrogens and androgens was previously addressed 290 
by Booth et al. (47-49). Castrated boars were treated with dihydrotestosterone, DHEA, estrone, 291 
or estradiol and prostate size along with other secondary sex glands were monitored. Only males 292 
administered estrone or estradiol showed significantly increased mass of prostate, seminal 293 
vesicles, and bulbourethral glands (47, 48), confirming that these accessory sex glands are 294 
dependent on estrogens. Interestingly, castrated boars administered DHEA, did not have 295 
detectable levels of free estrogens and did not have an increased prostate mass (47). This finding 296 
suggests that DHEA is unlikely to be a major estrogen precursor in the prostate consistent with 297 
primarily aromatase-independent synthesis of estrogens in the prostate. Our data extend these 298 
previous findings suggesting that the porcine prostate primarily synthesizes free estrogens from 299 
testicular estrogen sulfates, rather than from DHEA similar to the role of sulfatase proposed in 300 
the human prostate (9).  These results are also consistent with use of sulfatase inhibitors to 301 
inhibit local synthesis of active estrogens in prostate cancer therapy (46, 50, 51). Hence, although 302 
free estrogen concentrations are significantly decreased in the primary steroidogenic tissue, 303 
testes, and systemic circulation (32), free estrogens in a peripheral tissue, the prostate, were not 304 
affected. The ability of the prostate to function independently of testicular and systemic 305 
influences strongly suggests that future steroid-hormone therapeutic approaches should account 306 
for the contribution of steroid sulfates and sulfatase in steroid hormone production in a tissue. 307 
25 
 
Historically, sulfated steroid hormones in the systemic system were considered metabolic 308 
end products, primarily synthesized in the liver, that aid in excretion (52); although research has 309 
challenged and abandoned conceptions of this simple biological role and exclusive origin of 310 
steroid sulfates (3, 7, 53). Based on the current study, the boar liver likely does not drive or 311 
significantly impact systemic estrogen sulfate concentrations but likely functions to aid in 312 
excretion of circulating estrogens. The expression of estrogen receptors (54) and estrogen-313 
induced hepatocyte regeneration (55) suggest that liver can be a target for estrogens. 314 
Furthermore, the liver possesses metabolic machinery to both conjugate and de-conjugate 315 
estrogens (7, 27, 56), providing the ability to regulate estrogen concentrations and distribution of 316 
free estrogens independent of circulating concentrations. However, free estrogen levels were 317 
very low in the liver, suggesting minimal signaling.  318 
 Sulfated steroids in tissues can be altered after tissue collection by sulfatase enzymatic 319 
activity (30). However, homogenization of the frozen tissue in ice-cold methanol in the present 320 
study would be expected to denature these enzymes prior to significant conversion. The ratios of 321 
sulfated to free steroids in the present study are consistent with postharvest inhibition of sulfatase 322 
activity in the testis (30). 323 
Progestogen and gluco/mineralocorticoid synthesis and metabolism 324 
The predominance of C21 steroids detected in the testis is consistent with the testis as a 325 
primary endocrine gland in the boar. Pregnenolone and 17-hydroxypregnenolone were prominent 326 
in the testis and most likely function as intermediary compounds in testicular steroidogenesis 327 
(57); neither steroid is secreted in quantitatively significant amounts (26). Endogenous estrogens 328 
and androgens can be synthesized metabolically from pregnenolone via either the ∆5- or ∆4- 329 
pathway in the boar (28, 58). Metabolites in testis extract are consistent with predominance of 330 
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the ∆5- pathway in the testis and support presence of both pathways. These  results are consistent 331 
with the testis being the primary site for synthesis of systemic DHEA-sulfate (59, 60) as it is in 332 
most mammals other than primates (61).  333 
Production of steroid hormones in the prostate likely result from precursor steroids 334 
provided systemically.  The C21 steroid precursors, pregnenolone, 17-hydroxypregenenolone, 335 
and 17-hydroxyprogesterone, were not detectable suggesting they are not components of steroid 336 
synthesis within the prostate. Other steroid components of the ∆5- pathway were similarly not 337 
detectable in the prostate or liver and other components of the ∆4- pathway were not detectable 338 
or present in only minimal quantities. The lack of substantial free C21 steroids and paucity of the 339 
∆5- or ∆4- pathway metabolites, support the hypothesis that the boar prostate and liver utilize 340 
testis and/or adrenal derived steroids for local steroid hormone synthesis (7, 27) and contrasts 341 
with the abundance of these C21 steroid precursors in primary endocrine glands like the testis.  342 
Conclusion 343 
A multi-tissue approach in combination with aromatase inhibition and investigation of a 344 
broad array of steroids, revealed complexity and unique roles for individual organs in steroid 345 
hormone synthesis. Results from animals treated with letrozole displayed the primary role of the 346 
testis in synthesis of estrogens and estrogen sulfates, and suggested the dependence of the 347 
prostate on sulfated testis-derived steroid hormone precursors. Furthermore, individual organs 348 
may maintain tissue-specific profiles of active steroid hormones independent of systemic 349 
influences. Our research sheds light on the critical regulatory role of steroid sulfates in a tissue 350 
and suggests future research on the interplay of free and sulfo-conjugated steroid hormones 351 
within a tissue.  352 
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